On July 14, the House Appropriations Committee approved FY17 funding of $1.26 billion for Alzheimer's research at the National Institutes of Health, an increase of $350 million. This action follows the Senate Appropriations Committee budget of $1.39 billion, a $400 million increase. If passed by Congress, this would be the second year in a row federal funding hit a historic milestone.
TAKE ACTION NOW! (New window will open on click)
Note:This bill has now been incorporated by the Senate Appropriations Committee into the funding bill for Labor-HHS-Ed reported out to the full Senate. It is crucial that those battling Alzheimer's have access to diagnosis and care planning services which can lead to better outcomes for themselves, their families and their caregivers. That is why the Alzheimer's Association supports passage of the Health Outcomes, Planning and Education (HOPE) for Alzheimer's Act. The HOPE for Alzheimer's Act (S. 857/H.R. 1559) is legislation that would:
- Provide Medicare coverage for comprehensive care planning services following a dementia diagnosis; the services would be available to both the diagnosed individual and his/her caregiver.
- Ensure that documentation of a dementia diagnosis and any care planning provided is included in an individual’s medical record.
- Require the Department of Health and Human Services to educate providers about the new benefit and to identify any barriers individuals face in accessing care planning.
Who supports the HOPE for Alzheimer's Act? Thousands of advocates nationwide have contacted Congress to urge passage of this bill, and the Alzheimer's Association has worked to ensure that the bill has bipartisan support from members of Congress.